Poland· PL-100219439
Mobilat
A preparations with salicylic acid derivatives product containing mucopolisaccharidi polisulfas + suprarenali extractum + acidum salicylicum, registered in Poland by STADA Arzneimittel AG. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Mucopolisaccharidi polisulfas + suprarenali extractum + acidum salicylicum is registered in 8 of 19 countries.
Countries holding a registration under ATC M02AC (preparations with salicylic acid derivatives), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Mucopolisaccharidi polisulfas + suprarenali extractum + acidum salicylicum · ATC M02AC
8 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Mucopolisaccharidi polisulfas + Suprarenali extractum + Acidum salicylicum
- Manufacturer
- STADA Arzneimittel AG
- Country
- Poland (PL)
- ATC code
- M02AC
- ATC class
- Preparations with salicylic acid derivatives
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990022311
- gtin05909990022328
- gtin05909990022335
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under M02AC
Preparations with salicylic acid derivatives, as other registers publish it.
- FinlandAlgesalSolvay Pharma S.A.S.
- CzechiaALGESALPharmaselect International Beteiligungs GmbH, Vídeň
- CzechiaALGESALPharmaselect International Beteiligungs GmbH, Vídeň
- BelgiumAlgipan BalsemLaboratoria Qualiphar
- FinlandAntireemaTerpia Bernerin Lääketehdas Oy
- CzechiaARNIDOL SPRAYHarras Pharma Curarina Arzneimittel GmbH, Mnichov
- CzechiaARNIDOL SPRAYHarras Pharma Curarina Arzneimittel GmbH, Mnichov
- CanadaARTHRITIS PAIN RELIEFCHURCH & DWIGHT CANADA CORP
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/03b1f356-a7e6-49a9-99c6-702ca5539326 GET /v1/drugs/03b1f356-a7e6-49a9-99c6-702ca5539326?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Żel",
"source": "urpl",
"strength": "(0,2 g + 1 g + 2 g)/100 g",
"packaging": "05909990022311 ¦ OTC ¦ 6616\n1 tuba 50 g\n05909990022328 ¦ OTC ¦ 6617\n1 tuba 100 g\n05909990022335 ¦ OTC ¦ 15831\n1 tuba 25 g",
"substance": "Mucopolisaccharidum polisulphatum 0.2 g + Suprarenal extract 1 g + Acidum salicylicum 2 g",
"common_name": "Mucopolisaccharidi polisulfas + Suprarenali extractum + Acidum salicylicum",
"pl_product_id": "100219439",
"pozwolenie_nr": "00223",
"auth_procedure": "NAR",
"authorisation_validity": "2025-09-10"
}See everything about mucopolisaccharidi polisulfas + suprarenali extractum + acidum salicylicum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.